Necdin: A Multi Functional Protein with Potential Tumor Suppressor Role?

被引:24
作者
Chapman, Emma J. [1 ]
Knowles, Margaret A. [1 ]
机构
[1] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England
关键词
NDN; working hypothesis; candidate tumor suppressor gene; PRADER-WILLI-SYNDROME; HUMAN UROTHELIAL CELLS; TRANSCRIPTION FACTOR; GROWTH SUPPRESSOR; MAGE PROTEINS; BREAST-CANCER; EXPRESSION; GENE; DIFFERENTIATION; TELOMERASE;
D O I
10.1002/mc.20567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Necdin (NDN), a member of the melanoma-associated antigen (MAGE) family of proteins was first identified in mouse stem cells of embryonal carcinoma origin induced to differentiate by treatment with retinoic acid. The human gene maps to chromosome 15q11. This imprinted region is implicated in the pathogenesis of Prader-Willi syndrome (PWS), a neurodevelopmental disorder, where NDN is one of multiple genes silenced by deletion, maternal uniparental disomy or translocation. Due to this association, much interest has focused on the role of NDN in neuronal development and differentiation. However, a considerable number of studies have identified additional functions of NDN. Taken together these studies suggest a pleiotropic protein with diverse functions some of which may be relevant to tumorigenesis. Downregulation of NDN occurs in carcinoma cell lines and primary tumors, suggesting a tumor suppressor role. Our working hypothesis is that NDN is a worthy candidate for further studies with regard to a potential tumor suppressor role. In this article we outline the considerable evidence supporting the hypothesis that NDN has multiple functions, some of which indicate that it could be a tumor suppressor. The roles of NDN in key processes such as interaction with p53 and E2F-1, hematopoietic stem cell quiescence, transcriptional repression, angiogenesis, differentiation and interaction with the polycomb group gene BMI1 are discussed. Confirmation of NDN as a tumor suppressor may have implications for monitoring of PWS patients and could present a novel cancer therapeutic target. (C) 2009 Wiley-Liss, Inc.
引用
收藏
页码:975 / 981
页数:7
相关论文
共 44 条
[1]   The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease [J].
Barker, PA ;
Salehi, A .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (06) :705-712
[2]   The many faces of telomerase: emerging extratelomeric effects [J].
Bollmann, F. Mathias .
BIOESSAYS, 2008, 30 (08) :728-732
[3]   Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions [J].
Bracken, AP ;
Dietrich, N ;
Pasini, D ;
Hansen, KH ;
Helin, K .
GENES & DEVELOPMENT, 2006, 20 (09) :1123-1136
[4]   Msx2 and necdin combined activities are required for smooth muscle differentiation in mesoangioblast stem cells [J].
Brunelli, S ;
Tagliafico, E ;
De Angelis, FG ;
Tonlorenzi, R ;
Baesso, S ;
Ferrari, S ;
Niinobe, M ;
Yoshikawa, K ;
Schwartz, RJ ;
Bozzoni, I ;
Ferrari, S ;
Cossu, G .
CIRCULATION RESEARCH, 2004, 94 (12) :1571-1578
[5]   The Prader-Willi syndrome protein necdin interacts with the E1A-like inhibitor of differentiation EID-1 and promotes myoblast differentiation [J].
Bush, Jason R. ;
Wevrick, Rachel .
DIFFERENTIATION, 2008, 76 (09) :994-1005
[6]   Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway [J].
Chapman, E. J. ;
Hurst, C. D. ;
Pitt, E. ;
Chambers, P. ;
Aveyard, J. S. ;
Knowles, M. A. .
ONCOGENE, 2006, 25 (36) :5037-5045
[7]   Genes involved in differentiation, stem cell renewal, and tumorigenesis are modulated in telomerase-immortalized human urothelial cells [J].
Chapman, Emma J. ;
Kelly, Gavin ;
Knowles, Margaret A. .
MOLECULAR CANCER RESEARCH, 2008, 6 (07) :1154-1168
[8]   The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival [J].
Crawford, Nigel P. S. ;
Walker, Renard C. ;
Lukes, Luanne ;
Officewala, Jennifer S. ;
Williams, Robert W. ;
Hunter, Kent W. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (04) :357-369
[9]   Myeloid leukemia in Prader-Willi syndrome [J].
Davies, HD ;
Leusink, GL ;
McConnell, A ;
Deyell, M ;
Cassidy, SB ;
Rick, GH ;
Coppes, MJ .
JOURNAL OF PEDIATRICS, 2003, 142 (02) :174-178
[10]   BMI-1 promotes Ewing sarcoma tumorigenicity independent of CDKN2A repression [J].
Douglas, Dorothea ;
Hsu, Jessie Hao-Ru ;
Hung, Long ;
Cooper, Aaron ;
Abdueva, Diana ;
van Doorninck, John ;
Peng, Grace ;
Shimada, Hiro ;
Triche, Timothy J. ;
Lawlor, Elizabeth R. .
CANCER RESEARCH, 2008, 68 (16) :6507-6515